New device aims to seal brain aneurysms safely

NCT ID NCT04289480

Ongoing Disease control Sponsor: Medos International SARL Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times

Summary

This study looks at a device called ENTERPRISE 2 that helps doctors treat brain aneurysms (a bulging blood vessel in the brain). The device is used during a procedure to block the aneurysm with coils. The study includes 164 people aged 18 to 80 with certain types of brain aneurysms. Researchers will check if the aneurysm stays blocked at 6 months and 1 year after treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRACRANIAL ANEURYSM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain aneurysm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTRACRANIAL ANEURYSM

Contacts and locations

Locations

Beijing Anzhen Hospital, Capital Medical University

Beijing, Beijing Municipality, 100029, China
Beijing Tiantan Hospital, Capital Medical University

Beijing, Beijing Municipality, 100070, China
Huashan Hospital Shanghai Medical college, Fudan University

Shanghai, Shanghai Municipality, China
Nanjing Drum Tower Hospital

Nanjing, Jiangsu, 210008, China
Shengjing Hospital of China Medical University

Shenyang, Liaoning, 110004, China
The first affiliated hospital of Nanchang university

Nanchang, Jiangxi, 330006, China
The first affiliated hospital of Zhengzhou university

Zhengzhou, Henan, 450052, China
Union Hospital, Tongji Medical College, Huazhong University of Science & Technology

Wuhan, Hubei, 430022, China
Zhejiang Hospital

Hangzhou, Zhejiang, 310007, China
Zhujiang Hospital of Southern Medical University

Guangzhou, Guangdong, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.